148 related articles for article (PubMed ID: 346209)
1. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
Eilber FR; Grant T; Morton DL
Cancer Treat Rep; 1978 Feb; 62(2):213-6. PubMed ID: 346209
[TBL] [Abstract][Full Text] [Related]
2. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy for osteosarcoma.
Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
[TBL] [Abstract][Full Text] [Related]
6. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
[TBL] [Abstract][Full Text] [Related]
7. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM
Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
10. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
[TBL] [Abstract][Full Text] [Related]
11. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
12. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
13. [Surgery and adjuvant chemotherapy of osteosarcoma].
Yamawaki S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1576-83. PubMed ID: 3460527
[TBL] [Abstract][Full Text] [Related]
14. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
16. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
[TBL] [Abstract][Full Text] [Related]
17. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
[TBL] [Abstract][Full Text] [Related]
18. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma: the outcome of limb salvage surgery.
Faisham WI; Zulmi W; Halim AS; Biswal BM; Mutum SS
Med J Malaysia; 2004 Dec; 59 Suppl F():24-34. PubMed ID: 15941157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
